The president abruptly walked out of a meeting Wednesday, saying he would not negotiate with Democrats while they continue to investigate him.Politicsread more
Talk about 5G is everywhere right now, from the trade-war with China to the ban on Huawei. Here's what 5G is and why it matters.Technologyread more
When the Fed releases minutes of its last meeting on Wednesday afternoon, it risks sounding a bit hawkish.Market Insiderread more
Ireland's privacy watchdog, which leads supervision of Google in the EU, launched an inquiry into the firm's online advertising practices.Technologyread more
More voters in five key industrial states disapprove than approve of Trump's handling of trade — 56% to 41%, according to a report.Politicsread more
Americans in certain areas of the country have significantly higher average credit scores than others. Experian's annual State of Credit report shows the average score in each...Spendread more
Morgan Stanley caused a stir with its "bear case" scenario of $10. Now, Citi is getting in on the act.Investingread more
Target's CEO thinks the retail industry is shaking out to show clear winners and losers. Those companies that are investing in stores and online are winners, he said.Retailread more
A put credit spread is a good, risk-conscious way to trade the volatile semiconductor cohort, says TradingAnalysis.com founder Todd Gordon.Trading Nationread more
Treasury Secretary Steven Mnuchin says he has spoken with a top Walmart executive about how it can keep prices low amid the U.S.-China spat.Marketsread more
China is considering cutting natural gas purchases from the U.S. in its tit-for-tat strategy on trade, according to the South China Morning Post.Marketsread more
The merger combines CVS' pharmacies with Aetna's insurance business, blurring traditionally distinct lines in hopes of lowering costs. CVS also has one of largest pharmacy benefits managers through CVS Caremark and a major Medicare Part D plan sponsor through its SilverScript unit.
The final deal valued Aetna at $212 per share, CVS said in a press release, or about $70 billion, up from the previously agreed upon $207 per share, or roughly $69 billion. CVS will now need to integrate Aetna and start trying to accomplish its three main priorities: making health care local and accessible, simplifying how consumers access care and lowering costs.
"There's a lot of excitement and energy in both organizations, and folks are ready to roll up their sleeves and get to work," CVS CEO Larry Merlo told CNBC in an interview Wednesday.
Consumers won't immediately see any differences in their local stores, Merlo said. Early next year, CVS plans to start testing stores with added health services. These new locations will likely focus on managing common chronic conditions, adding more primary health services at CVS' MinuteClinics, guiding discharged hospital patients through their at-home plans and managing complex conditions.
From there, CVS will evaluate and tweak new store formats as necessary before rolling them out broadly.
"We'll be working hard so those opportunities will be coming as soon as possible," he said.
The two companies announced the deal in December 2017 and received preliminary approval from the Department of Justice in October. CVS needed final approval from state insurance regulators where Aetna sells its coverage. A handful of states opposed the combination, saying it would reduce competition and could leave consumers worse off.
In the end, CVS was able to persuade the state regulators to sign off on the acquisition. To win approval from California, CVS agreed to a number of conditions, including not raising premiums as a result of acquisition costs and keeping premium increases to a minimum. This came after Aetna said it would sell its Medicare Part D drug plan business to WellCare Health Plans for an undisclosed amount in order ease concerns about the overlap between the CVS and Aetna Medicare Part D plans.
On its third-quarter earnings call Nov. 6, CVS said it expects to save more than $750 million within two years of the deal closing. Merlo has promised the combined company will create a new data-driven health-care model that's more personal, convenient and tailored to individual patients than ever before.